MOLINA ARTURO MD 4
4 · Protagonist Therapeutics, Inc · Filed Nov 19, 2025
Insider Transaction Report
Form 4
MOLINA ARTURO MD
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-11-17$84.77/sh−2,712$229,896→ 81,180 total
Footnotes (1)
- [F1]Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.